(Q38538043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

Human T-lymphotropic virus 1

18 February 2020

main subject

0 references

author

David Nicolás

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Maria Angeles Marcos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Juan Ambrosioni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Roger Paredes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Christian Manzardo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Asunción Moreno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

José M Miró

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

25 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

947-963

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112187%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a new human retrovirus from West African patients with AIDS.

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Tracing the origin and history of the HIV-2 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HIV type 2 in New York City, 2000-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Slower heterosexual spread of HIV-2 than HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Genome organization and transactivation of the human immunodeficiency virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human immunodeficiency virus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Antiretroviral therapy response among HIV-2 infected patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HIV-2: the forgotten AIDS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Update on antiretroviral treatment during primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

British HIV Association guidelines for antiretroviral treatment of HIV‐2‐positive individuals 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Novel agents for the treatment of HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Special aspects of the treatment of HIV-2-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Transmitted drug resistance in French HIV-2-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Genotypic resistance profiles of HIV-2-treated patients in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Lack of protection against HIV-1 infection among women with HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Natural protection against HIV-1 infection provided by HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Effect of HIV-2 infection on HIV-1 disease progression and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Epidemiological Aspects and World Distribution of HTLV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human T cell leukemia virus-1 in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Adult T-cell leukemia: a review of epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HIV-1, HTLV-I, and HTLV-II in a semiurban population in East Gabon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Prevalence of HTLV-I-associated T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

A Severe Bite From a Nonhuman Primate Is a Major Risk Factor for HTLV-1 Infection in Hunters From Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Current status of HTLV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HTLV-1 in solid-organ transplantation: current challenges and future management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Therapeutic options for adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Biology and treatment of HTLV-1 associated T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Antiviral effect of raltegravir on HTLV-1 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Increased all-cause and cancer mortality in HTLV-II infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Human T-lymphotropic virus type II and neurological disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Short communication: Prevalence and risk factors for human T cell lymphotropic virus infection in Southern Brazilian HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

A gorilla reservoir for human T-lymphotropic virus type 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Serologic testing for human T-lymphotropic virus-3 and -4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157

HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1056157